Synthesis, biological evaluation and metadynamics simulations of novel N-methyl β-sheet breaker peptides as inhibitors of Alzheimer's β-amyloid fibrillogenesisElectronic supplementary information (ESI) available: Fig. S1–S32, Tables S1–S5, Texts S1–S3. See DOI: https://doi.org/10.1039/d4md00057a

Autor: Moraca, Federica, Vespoli, Ilaria, Mastroianni, Domenico, Piscopo, Vincenzo, Gaglione, Rosa, Arciello, Angela, De Nisco, Mauro, Pacifico, Severina, Catalanotti, Bruno, Pedatella, Silvana
Zdroj: MedChemComm; 2024, Vol. 15 Issue: 7 p2286-2299, 14p
Abstrakt: Several scientific evidences report that a central role in the pathogenesis of Alzheimer's disease is played by the deposition of insoluble aggregates of β-amyloid proteins in the brain. Because Aβ is self-assembling, one possible design strategy is to inhibit the aggregation of Aβ peptides using short peptide fragments homologous to the full-length wild-type Aβ protein. In the past years, several studies have reported on the synthesis of some short synthetic peptides called β-sheet breaker peptides (BSBPs). Herein, we present the synthesis of novel (cell-permeable) N-methyl BSBPs, designed based on literature information on the structural key features of BSBPs. Three-dimensional GRID-based pharmacophore peptide screening combined with PT-WTE metadynamics was performed to support the results of the design and microwave-assisted synthesis of peptides 2and 3prepared and analyzed for their fibrillogenesis inhibition activity and cytotoxicity. An HR-MS-based cell metabolomic approach highlighted their cell permeability properties.
Databáze: Supplemental Index